Rhone Ma Holdings Bhd (5278) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.234x

Based on the latest financial reports, Rhone Ma Holdings Bhd (5278) has a cash flow conversion efficiency ratio of 0.234x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (RM41.17 Million ≈ $10.34 Million USD) by net assets (RM175.69 Million ≈ $44.11 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 5278 equity to assets ratio to measure how much of total assets are equity-financed.

Rhone Ma Holdings Bhd - Cash Flow Conversion Efficiency Trend (2015–2025)

This chart illustrates how Rhone Ma Holdings Bhd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Rhone Ma Holdings Bhd cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Rhone Ma Holdings Bhd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Rhone Ma Holdings Bhd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Rothwell International Co. Limited KQ:900260	0.415x
NOMADAR Corp. Class A Common Stock NASDAQ:NOMA	-0.287x
Bestec Power Electronics Co Ltd TW:3308	-0.023x
Transworld Shipping Lines Limited NSE:TRANSWORLD	0.088x
Culp, Inc. Common Stock NASDAQ:CULP	-0.022x
MNC Vision Networks PT JK:IPTV	0.015x
Respiri Ltd AU:RSH	-0.863x
FRIWO AG F:CEA	-0.013x

Annual Cash Flow Conversion Efficiency for Rhone Ma Holdings Bhd (2015–2025)

The table below shows the annual cash flow conversion efficiency of Rhone Ma Holdings Bhd from 2015 to 2025. For the full company profile with market capitalisation and key ratios, see Rhone Ma Holdings Bhd (5278) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	RM175.69 Million ≈ $44.11 Million	RM41.17 Million ≈ $10.34 Million	0.234x	+128.08%
2024-12-31	RM179.21 Million ≈ $44.99 Million	RM18.41 Million ≈ $4.62 Million	0.103x	+305.99%
2023-12-31	RM160.98 Million ≈ $40.42 Million	RM-8.03 Million ≈ $-2.02 Million	-0.050x	-113.38%
2022-12-31	RM153.34 Million ≈ $38.50 Million	RM-3.58 Million ≈ $-899.82K	-0.023x	-127.45%
2021-12-31	RM131.36 Million ≈ $32.98 Million	RM11.19 Million ≈ $2.81 Million	0.085x	-37.62%
2020-12-31	RM124.11 Million ≈ $31.16 Million	RM16.94 Million ≈ $4.25 Million	0.137x	+97.44%
2019-12-31	RM107.33 Million ≈ $26.95 Million	RM7.42 Million ≈ $1.86 Million	0.069x	+3.98%
2018-12-31	RM104.19 Million ≈ $26.16 Million	RM6.93 Million ≈ $1.74 Million	0.066x	+50.29%
2017-12-31	RM102.43 Million ≈ $25.72 Million	RM4.53 Million ≈ $1.14 Million	0.044x	-39.36%
2016-12-31	RM95.16 Million ≈ $23.89 Million	RM6.94 Million ≈ $1.74 Million	0.073x	-51.50%
2015-12-31	RM55.60 Million ≈ $13.96 Million	RM8.36 Million ≈ $2.10 Million	0.150x	--

About Rhone Ma Holdings Bhd

KLSE:5278 Malaysia Drug Manufacturers - Specialty & Generic

Market Cap

$39.02 Million

RM155.41 Million MYR

Market Cap Rank

#22797 Global

#533 in Malaysia

Share Price

RM0.70

Change (1 day)

+0.00%

52-Week Range

RM0.62 - RM0.72

All Time High

RM1.04